Feasibility and safety results from RAD-IO: A multi-stage trial of durvalumab (Medi4736) with chemoradiotherapy with 5-fluorouracil and mitomycin C in patients with muscle-invasive bladder cancer.
Compugen's innovative approach targets under-explored immune pathways like PVRIG and IL-18 binding protein. Read why I'm ...
The DeGregorio Family Foundation with support from the Torrey Coast Foundation Gastro Esophageal Investigator Network ...
While immune checkpoint blockade therapies, a type of immunotherapy that uses drugs to block specific proteins on immune cells called "checkpoints" from fully attacking cancer cells, have shown ...
Discover a study that describes a host-intrinsic mechanism responsible for the failure of PD-L1 blockade in ovarian cancer.
A new study shows that neutralising GDF-15 restores immune response in advanced cancers resistant to PD-1 blockade.
However, some nerve fibers remained active and continued promoting cancer growth. To completely cut off nerve support, the ...
Safety and efficacy of FGFR inhibitors in urothelial carcinoma: A systematic review and meta-analysis. Efficacy and safety of tislelizumab (T) combined with gemcitabine and cisplatin (GC) for patients ...
Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...
Funding from Cancer Prevention and Research Institute of Texas has brought more than 324 distinguished cancer researchers to Texas.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果